Alyftrek 10-50-125 MG tablet 14S
Ended Awarded
- Contract number
- SPE2DB25FZL15
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $20,993
Award facts
- Contract value 100% obligated
- $20,993.31 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
On September 16, 2025, the Defense Logistics Agency awarded a delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Alyftrek 10-50-125 mg tablets in quantities of 14 units. This firm fixed-price delivery order, valued at approximately $21K, was issued without a set-aside designation and carries an ultimate completion date of September 17, 2025. The award leverages DMS Pharmaceutical Group's position as a critical supplier within the federal pharmaceutical supply chain, serving Defense Department healthcare facilities nationwide.
This delivery order is issued under DMS Pharmaceutical Group's existing single-award Indefinite Delivery Contract with the Defense Logistics Agency under the SPE2DB program, a comprehensive pharmaceutical supply vehicle valued at $500M and valid through November 2026. DMS Pharmaceutical Group specializes in distributing branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables to military and federal healthcare systems. The company has consistently maintained a robust portfolio of pharmaceutical contract awards with the Defense Logistics Agency, demonstrating its established capability to meet the medical supply requirements of Department of Defense healthcare operations globally.
Quick answers
Who was awarded contract SPE2DB25FZL15?
SPE2DB25FZL15 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on September 16, 2025.
How much is contract SPE2DB25FZL15 worth?
The government has obligated $20,993 on SPE2DB25FZL15.
Is contract SPE2DB25FZL15 an order under another contract?
Yes. SPE2DB25FZL15 is a delivery order under SPE2DB20D9329, an indefinite delivery contract.
Was contract SPE2DB25FZL15 competed?
The extent of competition for SPE2DB25FZL15 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award